Parathyroid Hormone and the Myocardiopathy of Chronic Renal Failure

  • Shaul G. Massry
  • Miroslaw Smogorzewski
  • Alessandra F. Perna
Part of the Topics in Renal Medicine book series (TIRM, volume 10)

Abstract

Patients with advanced chronic renal failure (CRF) and those treated with dialysis display a large number of cardiovascular complications. These are listed in table 9–1. These patients may suffer from myocardial disease [1–6], and several factors have been implicated in its genesis (table 9–2). These include anemia, electrolyte disturbances, acidosis, and hypertension [5–7]. Accelerated atherogenesis has also been suggested as the cause of myocardial disease in many of these patients [8]. Drueke et al. [9] reported that 7 of 21 hemodialysis patients with congestive myocardiopathy did not have angiographic evidence of coronary artery disease or other causes for the myocardiopathy. Others [6] also reported myocardiopathy of unexplained etiology, and the cardiac disease was attributed to “ uremic toxins,” but the nature and characteristics of a uremic toxin that acts on the myocardium were not identified.

Keywords

Anemia Radionuclide Cardiomyopathy NADH Succinate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ritcher AB, O’Hare JP. 1963. Heart in chronic glomerulonephritis. N Engl J Med 266: 1089–1097.Google Scholar
  2. 2.
    Gouley BA. 1940. The myocardial degeneration associated with uremia in advanced hypertension disease and chronic glomerulonephritis. Am J Med Sci 200:39–53.CrossRefGoogle Scholar
  3. 3.
    Solomon C, Roberts JE, Lisa JR. 1942. The heart in uremia. Am J Pathol 18:729–732.PubMedGoogle Scholar
  4. 4.
    Legendorf R, Pirani LC. 1947. The heart in uremia. An electrocardiographic and pathologic study. Am Heart J 33:382–307.Google Scholar
  5. 5.
    Derow HW. 1954. The heart in renal disease. Circulation 10:114–128.PubMedCrossRefGoogle Scholar
  6. 6.
    Bailey GL, Hampers CL, Merrill JP. 1967. Reversible cardiomyopathy in uremia. Trans Am Soc Artif Intern Organs 13:263–272.Google Scholar
  7. 7.
    Pabico RC, Freeman RB. 1976. Pericarditis and myocardiopathy. In Massry SG, Sellers A(eds), Clinical Aspects of Uremia and Dialysis. Springfield: Thomas, pp. 69–99.Google Scholar
  8. 8.
    Linder A, Charra B, Sherrard DJ, Scribner BH. 1974. Accelerated atherogenesis of prolonged maintenance hemodialysis. N Engl J Med 290:697–701.CrossRefGoogle Scholar
  9. 9.
    Drueke T, LePailleur C, Sigal-Saglier M, Zingnoff J, Crosnier T, Matteo JD. 1981. Left ventricular function in hemodialyzed patients with cardiomegaly. Nephron 28:80–87.PubMedCrossRefGoogle Scholar
  10. 10.
    Seyle J. 1961. The Pleuricausal Cardiopathies. Springfield: Thomas.Google Scholar
  11. 11.
    Lehr D. 1966. The role of certain electrolytes and hormones in disseminated myocardial necrosis. In Bejusz E. (ed), Electrolyte and Cardiovascular Disease, vol. 1. Basel: Karger, p. 208.Google Scholar
  12. 12.
    Kraikitpanitch S, Linderman RD, Yunice AA, Baxter DJ, Haygood CC, Blue MD. 1978. Effect of azotemia on myocardial accumulation of calcium. Mineral Electrolyte Metab 1:12–20.Google Scholar
  13. 13.
    Wallach S, Bellavia JV, Schorr, J, SchafTer A. 1966. Tissue disturbances of electrolyte, Ca47, Mg28 in experimental hyper and hypoparathyroidism. Endocrinology 78:16–28.PubMedCrossRefGoogle Scholar
  14. 14.
    Borle AB. 1968. Calcium metabolism in Hela cells and the effect of parathyroid hormone. J Cell Biol 36:567–582.PubMedCrossRefGoogle Scholar
  15. 15.
    Borle AB. 1968. Effect of purified parathyroid hormone on the calcium metabolism of monkey kidney cells. Endocrinology 83:1316–1322.PubMedCrossRefGoogle Scholar
  16. 16.
    Borle AB. 1970. Kinetic analysis of calcium movement in cell culture. III. Effect of calcium and parathyroid hormone on kidney cells. J Gen Physiol 55:163–186.Google Scholar
  17. 17.
    Chausmer AB, Sherman BS, Wallach S. 1972. The effect of parathyroid hormone on hepatic cell transport of calcium. Endocrinology 90:663–672.PubMedCrossRefGoogle Scholar
  18. 18.
    Borle AB. 1973. Calcium metabolism at the cellular level. Fed Proc 30:1944–1950.Google Scholar
  19. 19.
    Massry SG, Coburn JW, Hartenbower DL, Shinaberger JH, DePalma JR, Champan E, Kleeman CR. 1970. Mineral content of human skin in uremia: Effect of secondary hyperparathyroidism and hemodialysis. Proc Eur Dial Transplant Assoc 7:146–150.Google Scholar
  20. 20.
    Berkow JW, Fine BS, Zimmermann EE.1968. Unusual ocular calcification in hyperparathyroidism. Am J Ophthalmol 66:812–824.PubMedGoogle Scholar
  21. 21.
    Berstein SS, Pletka P, Hattner RS, Hampers CL, Merrill JP. 1971. Effect of total parathyroidectomy and uremia on the chemical composition of bone, skin, and aorta in the rat. Israel J Med Sci 7:513–514.Google Scholar
  22. 22.
    Guisado R, Arieff AI, Massry SG. 1977. Muscle, water and electrolytes in uremia and the effect of hemodialysis. J Lab Clin Med 89:322–331.PubMedGoogle Scholar
  23. 23.
    Arieff AI, Massry, SG. 1974. Calcium metabolism of brain in acute renal failure. J Clin Invest 53:387–392.PubMedCrossRefGoogle Scholar
  24. 24.
    Goldstein DA, Massry SG. 1978. Effect of parathyroid hormone administration and its withdrawal on brain calcium and electroencephalogram. Mineral Electrolyte Metab 1:84–91.Google Scholar
  25. 25.
    Akmal M, Goldstein DA, Multani S, Massry SG. 1984. Role of uremia, brain calcium and parathyroid hormone on changes in electroencephalogram in chronic renal failure. Am J Physiol 246(Renal Fluid Electrolyte Physiol 15):F575–F579.PubMedGoogle Scholar
  26. 26.
    Smogorzewski M, Campese VM, Massry SG. 1989. Abnormal norepinephrine uptake and release in brain synaptosomes in chronic renal failure. Kidney Int 36:458–465.PubMedCrossRefGoogle Scholar
  27. 27.
    Goldstein DA, Chui LA, Massry SG. 1978. Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity. J Clin Invest 62:88–93.PubMedCrossRefGoogle Scholar
  28. 28.
    Akmal M, Massry SG. 1990. Role of PTH in the prolonged motor nerve conduction velocity of chronic renal failure. Proc Exp Biol Med 195:202–207.Google Scholar
  29. 29.
    Fadda GZ, Akmal M, Prendas FH, Lipson LG, Massry SG. 1988. Insulin release from pancreatic islets: Effect of CRF and excess PTH. Kidney Int 33:1066–1072.PubMedCrossRefGoogle Scholar
  30. 30.
    Perna AF, Fadda GZ, Zhou X-J, Massry SG. 1990. Mechanism of impaired insulin secretion after chronic excess of parathyroid hormone. Am J Physiol 259:F210–F216.PubMedGoogle Scholar
  31. 31.
    Fadda GZ, Hajjar SM, Perna AF, Zhou X-J, Lipson LG, Massry SG. 1991. On the mechanism of impaired insulin secretion in chronic renal failure. J Clin Invest 87:255–261.PubMedCrossRefGoogle Scholar
  32. 32.
    Smogorzewski M, Koureta P, Fadda GZ, Perna AF, Massry SG. 1991. Parathyroid hormone increases resting levels of cytosolic calcium in brain synaptosomes: studies in the presence and absence of chronic renal failure. J Am Soc Nephrol 1:1162–1168.PubMedGoogle Scholar
  33. 33.
    Wave JA, Clark BA, Smith M, Salzman EW. 1989. Abnormalities in cytoplasmic Ca2+ in platelets from patients with uremia. Blood 73:172–176.Google Scholar
  34. 34.
    Alexiewicz JM, Gaciong Z, Klinger M, Linker-Israeli M, Pitts TO, Massry SG. 1991. Evidence of impaired T cell function in hemodialysis patients: Potential role for secondary hyperparathyroidism. Am J Nephrol 10:495–501.CrossRefGoogle Scholar
  35. 35.
    Gaciong Z, Alexiewicz JM, Linker-Israeli M, Shulman I, Pitts TO, Massry SG. 1991. Inhibition of immunoglobulin production by parathyroid hormone: Implications in chronic renal failure. Kidney Int 40:96–106.PubMedCrossRefGoogle Scholar
  36. 36.
    Alexiewicz JM, Smogorzewski M, Fadda GZ, Massry SG. 1991. Impaired phagocytosis in dialysis patients: studies on mechanism. Am J Nephrol 11:102–111.PubMedCrossRefGoogle Scholar
  37. 37.
    Baczynski R, Massry SG, Magott M, El-belbessi, Kohan, R, Brautbar N. 1985. Effect of parathyroid hormone on energy metabolism of skeletal muscle. Kidney Int 28:722–727.PubMedCrossRefGoogle Scholar
  38. 38.
    Perna AF. Smogorzewski M, Massry SG. 1988. Verapamil reverses PTH-or CRF-induced abnormal fatty acids oxidation in muscle. Kidney Int 34:774–778.PubMedCrossRefGoogle Scholar
  39. 39.
    Alexiewicz, JM, Klinger M, Pitts TO, Gaciong, Z, Linker-Israeli M, Massry SG. 1990. Parathyroid hormone inhibits B cell proliferation: Implications in chronic renal failure. J Am Soc Nephrol 1:236–244.PubMedGoogle Scholar
  40. 40.
    Pappenheimer AM, Wilens SL. 1935. Enlargement of the parathyroid glands in renal disease. Am J Pathol 11:73–91.PubMedGoogle Scholar
  41. 41.
    Roth SI, Marshal RB. 1969. Pathology and ultrastructure of the human parathyroid glands in chronic renal failure. Arch Intern Med 124:397–407.PubMedCrossRefGoogle Scholar
  42. 42.
    Katz AU, Hampers CL, Merrill JP. 1969. Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Medicine 84:333–374.Google Scholar
  43. 43.
    Berson SG, Yalow RS. 1966. Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia and bronchogenic carcinoma. Science 154:907–909.PubMedCrossRefGoogle Scholar
  44. 44.
    Massry SG, Coburn JW, Peacock M, Kleeman CR. 1972. Turnover of endogenous parathyroid hormone in uremic patients and those undergoing hemodialysis. Trans Am Soc Artif Internal Organs 18:416–422.CrossRefGoogle Scholar
  45. 45.
    Arnaud CD. 1973. Hyperparthyroidism and renal failure. Kidney Int 4:89–95.PubMedCrossRefGoogle Scholar
  46. 46.
    Bogin E, Massry SG, Harary I. 1981. Effect of parathyroid hormone on rat heart cells. J Clin Invest 67:1215–1227.PubMedCrossRefGoogle Scholar
  47. 47.
    Lhoste F, Drueke T, Larus S, Boissier JR. 1980. Cardiac interaction between parathyroid hormone, β-adrenoceptor, and verapamil in the guinea-pig in vitro. Clin Exp Pharmacol Physiol 7:377–385.CrossRefGoogle Scholar
  48. 48.
    Nayler WG. 1967. Some factors involved in the maintenance and regulation of cardiac contractility. Circ Res 21(Suppl III):213–221.Google Scholar
  49. 49.
    Katoh Y, Klein KL, Kaplan RA, Sanborn WG, Kurokawa K. 1981. Parathyroid hormone has a positive inotropic action in the rat. Endocrinology 109:2252–2253.PubMedCrossRefGoogle Scholar
  50. 50.
    Bogin E, Levi J, Harary I, Massry SG. 1982. Effect of parathyroid hormone on oxidative phosphorylation of heart mitochondria. Mineral Electrolyte Metab 7:151–156.Google Scholar
  51. 51.
    Baczynski R, Massry SG, Kohan R, Magott M, Saglikes Y, Brautbar N. 1985. Effect of parathyroid hormone on myocardial energy metabolism in the heart. Kidney Int 27: 718–725.PubMedCrossRefGoogle Scholar
  52. 52.
    El-Belbessi S, Brautbar N, Anderson K, Campese VM, Massry SG. 1986. Effect of chronic renal failure on heart: role of secondary hyperparathyroidism. Am J Nephrol 6:369–395.PubMedCrossRefGoogle Scholar
  53. 53.
    Perna AF, Zayed MA, Massry SG. 1991. Impaired activity of α-ketoglutarate dehydrogenase of heart mitochondria in CRF: Role of secondary hyperparathyroidism. Nephron 17:8–11.Google Scholar
  54. 54.
    Capasso G, Tepper D, Capasso J, Sonnenblick EH. 1986. Effects of hypothyroidism and hypoparathyroidism on rat myocardium: mechanical and electrical alterations. Am J Med Sci 291:232–240.PubMedCrossRefGoogle Scholar
  55. 55.
    Kaye MA, Reiss NA, Weisman Y, Binderman I, Sourjen D. 1986. Hormonal regulation of creatine kinase BB. In Brautbar, N(ed), Myocardial and Skeletal Muscle Bioenergetics. Adv Exp Med Biol 194:83–101.Google Scholar
  56. 56.
    Zahavi I, Chagnac A, Djaldetti M, Katz A, Levi J.1985. Effects of verapamil on uremic myocardial disease in the rat. J Submicrosc Cytol 17:637–644.PubMedGoogle Scholar
  57. 57.
    Goligorsky MS, Chaimovitz C, Rapport J, Goldstein J, Kol R. 1985. Calcium metabolism in uremic nephrocalcinosis: preventive effect of verapamil. Kidney Int 27:774–779.PubMedCrossRefGoogle Scholar
  58. 58.
    Neely JR, Rovetto M, Oram MJ. 1972. Myocardial utilization of carbohydrate and lipid. Prog Cardiovasc Dis 15:289–324.PubMedCrossRefGoogle Scholar
  59. 59.
    Neely JR, Morgan HE. 1974. Relationship between carbohydrate and lipid metabolism and energy balance of heart muscle. Ann Rev Physiol 36:413–459.CrossRefGoogle Scholar
  60. 60.
    Ricanati ES, Tseng K, Hoppel CL. 1987. Abnormal fatty acid utilization during prolonged fasting in chronic uremia. Kidney Int 32:5145–5148.Google Scholar
  61. 61.
    Smogorzewski M, Perna AF, Borum PR, Massry SG. 1988. Fatty acid oxidation in the myocardium: effects of parathyroid hormone and CRF. Kidney Int 34:797–803.PubMedCrossRefGoogle Scholar
  62. 62.
    Perna AF, Smogorzewski M, Massry SG. 1989. Effects of verapamil on the abnormalities in fatty acid oxidation of myocardium. Kidney Int 36:453–457.PubMedCrossRefGoogle Scholar
  63. 63.
    Palmieri GMA, Nutting DF, Bhattacharya, Bertorini TE, Williams JC. 1981. Parathyroid ablation in dystrophic hamsters: Effects on Ca content and histology of heart, diaphragm and rectus femoris. J Clin Invest 68:646–654.PubMedCrossRefGoogle Scholar
  64. 64.
    Drueke T, Fleury J, Toure Y, DeVernejoul P, Fauchet M, Lesour P, LePailleu C, Crosnier J. ai]1980. Effet of parathyroidectomy on left ventricular function in hemodialysis patients. Lancet 1:112–114.Google Scholar
  65. 65.
    McGonigle RJS, Fowler MB, Timmis AB, Weston MJ, Parsons V. 1984. Uremic cardio-myopathy: potential role of vitamin D and parathyroid hormone. Nephron 36:94–100.PubMedCrossRefGoogle Scholar
  66. 66.
    Lai KN, Ng J, Whitford J, Buttfield I, Fasset RG, Mathew TH.1985. Left ventricular function in uremia: Echocardiographic and radionuclide assessment in patients on maintenance hemodialysis. Clin Nephrol 23:125–133.PubMedGoogle Scholar
  67. 67.
    Symons C, Fortune F, Greenbaum RA, Dandona P.1985. Cardiac hypertrophy, hypertrophic cardiomyopathy and hyperparathyroidism— an association. Br Heart J 54:539–542.PubMedCrossRefGoogle Scholar
  68. 68.
    Parfrey PS, Harnett JD, Griffiths S, Gault MH, Barre PE, Guttmann RD. 1987. Low-output left ventricular failure in end-stage renal disease. Am J Nephrol 7:184–191.PubMedCrossRefGoogle Scholar
  69. 69.
    London GM, Fabiani F, Marchais SJ, DeVernejoul MCh, Guerin A, Safar ME, Metivier F, Llach F. 1987. Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int 31:973–980.PubMedCrossRefGoogle Scholar
  70. 70.
    London GM, DeVernejoul MCh, Fabiani F, Marchais SJ, Guerin AP, Metivier F, London AM, Llach F. 1987. Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. Kidney Int 32:900–907.PubMedCrossRefGoogle Scholar
  71. 71.
    London GM, Marchais SJ, Guerin AP, Metivier F. 1989. Contributive factors to cardiovascular hypertrophy in renal failure. Am J Hypertension 2:261S–265S.Google Scholar
  72. 72.
    MacDonald IL, Uldall R, Buda AJ. 1981. The effect of hemodialysis on cardiac rhythm and performance. Clin Nephrol 15:321–327.PubMedGoogle Scholar
  73. 73.
    Madsen BR, Alpert MA, Whiting RB, Van Stone J, Ahmad M, Kelly DL. 1984. Effect of hemodialysis on left ventricular performance. Analysis of echocardiographic subsets. Am J Nephrol 4:86–91.Google Scholar
  74. 74.
    Nixon JV, Mitchell JH, McPhaul JJ, Henrich WL. 1983. Effect of hemodialysis on left ventricular function. Dissociation of changes in filling volume and in contractile state. J Clin Invest 71:377–384.Google Scholar
  75. 75.
    Zucchelli P, Santoro A, Zucchelli A, Spongano M, Ferrari G. 1988. Long-term effects of parathyroidectomy on cardiac and autonomic nervous system function in hemodialysis patients. Nephrol Dial Transplant 3:45–50.PubMedGoogle Scholar
  76. 76.
    Himelman RB, Helms CA, Schiller NB. 1988. Is parathormone a cardiac toxin in uremia? Int J Cardiac Imaging 3:209–215.CrossRefGoogle Scholar
  77. 77.
    Massry SG. 1979. Role of parathyroid hormone in the pathogensis of the uremic manifestations. Klin Wochenschr 57:1085–1088.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Shaul G. Massry
  • Miroslaw Smogorzewski
  • Alessandra F. Perna

There are no affiliations available

Personalised recommendations